PIERS and BIS, sFIT:PIGF, Adrenomedullin
Sensitivity and Specificity of Bispectral Index (BIS) EEG Parameter, sFIT (Soluble FMS Tyrosine Kinase): PIGF (Placental Growth Factor) Ratio, Adrenomedullin for Grading Preeclampsia Integrated Estimate Risk Score (PIERS)
Suez Canal University
48 participants
Oct 1, 2016
OBSERVATIONAL
Conditions
Summary
Pre-eclampsia, more than being proteinuric gestational hypertension alone, is a state of exaggerated systemic inflammation and remains a leading direct cause of maternal morbidity and mortality worldwide.1 Standardization of antenatal and postnatal assessment and surveillance of pre-eclampsia with protocols that recognize the systemic inflammatory model of preeclampsia have been associated with reduced maternal morbidity.
Eligibility
Inclusion Criteria3
- Pregnancy at any stage (3 trimesters)
- Eclampsia (Frank eclampsia) will be the crux of the study
- Pre-eclampsia that is suspected will end up with Frank Eclampsia
Exclusion Criteria2
- Any neurological conditions that can alter the electroencephalography like epilepsy
- Any medical conditions that can alter the electroencephalography like hypoglycemia
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02578810